Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What’s Old is New

Commonly used adjuvant systemic therapies harbor high rates of severe short-term and long-term side effects but are often justified to patients because of curative intent in early stage breast cancer. One of the oldest and least toxic adjuvant regimens, oral cyclophosphamide given with intravenous m...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Breast Cancer
Egile Nagusiak: Cho, Eunpi, Schwemm, Ann, Rubinstein, Lena, Stevenson, Phillip, Gooley, Ted A., Ellis, Georgiana, Specht, Jennifer M., Livingston, Robert B., Linden, Hannah M., Gadi, Vijayakrishna K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4568144/
https://ncbi.nlm.nih.gov/pubmed/26025883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2015.04.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak